blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3181150

EP3181150 - PHARMACEUTICAL COMPOSITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.03.2021
Database last updated on 13.09.2024
FormerExamination is in progress
Status updated on  14.05.2019
FormerRequest for examination was made
Status updated on  28.12.2017
FormerThe application has been published
Status updated on  19.05.2017
Most recent event   Tooltip05.03.2021Application deemed to be withdrawnpublished on 07.04.2021  [2021/14]
Applicant(s)For all designated states
Analyticon Discovery GmbH
Hermannswerder Haus 17
14473 Potsdam / DE
For all designated states
B.R.A.I.N. Biotechnology Research And Information Network AG
Darmstädter Strasse 34-36
64673 Zwingenberg / DE
[2017/25]
Inventor(s)01 / Siems, Karsten
Feuerbachstraße 7
14552 Michendorf / DE
02 / Riedel, Katja
Mierendorffstraße 36
64625 Bensheim / DE
03 / Krohn, Michael
Alexanderstrasse 8
64653 Lorsch / DE
 [2017/25]
Representative(s)Fabry, Bernd
IP2 Patentanwalts GmbH
Schlossstrasse 523-525
41238 Mönchengladbach / DE
[2017/25]
Application number, filing date15201444.519.12.2015
[2017/25]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP3181150
Date:21.06.2017
Language:DE
[2017/25]
Search report(s)(Supplementary) European search report - dispatched on:EP21.09.2016
ClassificationIPC:A61K45/06, A61K31/167, A61K31/19, A61K31/192, A61P29/00, A61K9/00
[2017/25]
CPC:
A61K31/19 (EP,US); A61K31/167 (EP,US); A61K31/192 (EP,US);
A61K31/381 (EP,US); A61K31/404 (EP,US); A61K31/616 (EP,US);
A61K45/06 (EP,US); A61K47/12 (US); A61K47/183 (US);
A61K47/26 (US); A61K47/38 (US); A61K47/42 (US);
A61K9/0053 (US); A61P29/00 (EP,US) (-)
C-Set:
A61K31/167, A61K2300/00 (US,EP);
A61K31/192, A61K2300/00 (US,EP);
A61K31/19, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/04]
Former [2017/25]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:PHARMAZEUTISCHE ZUBEREITUNGEN[2017/25]
English:PHARMACEUTICAL COMPOSITIONS[2017/25]
French:COMPOSITIONS PHARMACEUTIQUES[2017/25]
Examination procedure19.12.2015Date on which the examining division has become responsible
13.12.2017Amendment by applicant (claims and/or description)
13.12.2017Examination requested  [2018/04]
17.05.2019Despatch of a communication from the examining division (Time limit: M04)
17.09.2019Reply to a communication from the examining division
21.04.2020Despatch of a communication from the examining division (Time limit: M06)
03.11.2020Application deemed to be withdrawn, date of legal effect  [2021/14]
25.11.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/14]
Fees paidRenewal fee
28.12.2017Renewal fee patent year 03
21.12.2018Renewal fee patent year 04
17.12.2019Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.12.202006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US6365634  (RUSSELL BRETT A [US], et al) [Y] 1-12,14,15 * column 19, line 21 - line 23 *;
 [XYI]JP2006312590  (SUNSTAR INC) [X] 1-3,5,7-9,12 * paragraphs [0033] , [0034]; examples 7,8 * [Y] 1-12,14,15 [I] 4,6,10,11;
 [Y]WO2007040005  (UNIV KYOTO [JP], et al) [Y] 1-12,14,15 * example 3 *;
 [Y]  - SEPULVEDA ET AL, "Gastroprotective and cytotoxic effect of dehydroabietic acid derivatives", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, (20051101), vol. 52, no. 5, doi:10.1016/J.PHRS.2005.06.004, ISSN 1043-6618, pages 429 - 437, XP005126455 [Y] 1-12,14,15 * Compound 8;; figure 1; table 6 *

DOI:   http://dx.doi.org/10.1016/j.phrs.2005.06.004
by applicantUS4251195
 EP0389700
 US5286500
 WO0101926
 WO0101927
 WO0101928
 WO0101929
 US6214376
 WO02091849
 EP1064088
 WO03055587
 WO2004050069
 DE102006051529
    - SONG ET AL., JOURNAL OF WOOD CHEMISTRY AND TECHNOLOGY, (1985), vol. 5, no. 4, pages 535 - 542
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.